RFP QuestBeta
Awarded · ResultStage · contract

NHS England

Regulatory Work to Secure Licence Variation for anastrozole

Medical Equipment & PharmaCPV 33600000 85149000
Value£1
Awarded7 Feb 2022
Published27 May 2022
RegionLondon
Outcome — awarded

This is a contract result notice, not an open opportunity. Details from the official award data.

Contract value in context
£1total contract value
median £123k
this tender£0£16.5m

This sits below the typical range for Medical Equipment & Pharmaceuticals contracts — a smaller, more accessible award. Based on 9,456 valued Medical Equipment & Pharmaceuticals tenders in our corpus.

The brief

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole.

The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority.

In return the Authority will fund actual and reasonably incurred costs associated with obtaining this licence variation only.

Requirements

What the notice asks for

01

This Tender is solely for the work

This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole.

02

The successful Bidder will be responsible

The successful Bidder will be responsible for ensuring that all relevant MHRA conditions and documentation for the Marketing Authorisation variation are met and submitted within the time limits agreed with the Authority.

Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.

The gates

What this notice demands of you

1 named, none in explicit obligation language. Each one is quoted from the notice.

MHRARegulator registrations
This Tender is solely for the work involved to apply for and implement a major (type II) MHRA Marketing Authorisation variation to add a new clinical indication for anastrozole.

Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.

Buyer intelligence

Make the case to bid

Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.

Sign up free to unlock buyer intelligence

Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.

Source & provenance
OCID
6c3af4d4-10c7-4b77-9f21-6455ad0e5c2c
Stage
contract · Contract
Source
Contracts Finder
Buyer ref
CF-0869500D0O000000rwimUAA1
View the original notice on Contracts Finder

Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.

Market context

Who wins this kind of work

The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.

Top suppliers & buyers in Medical Equipment & Pharmaceuticals

This view needs WebGL, which this browser has turned off.

NHS England’s tender network

This view needs WebGL, which this browser has turned off.